Pieris Pharmaceuticals, Inc(NASDAQ:PIRS) 
Pieris Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, discovers and develops anticalin-based drugs in the United States. The company develops anticalin proteins that are low molecular-weight therapeutic proteins derived from lipocalins, which are naturally occurring low-molecular...
Website: http://www.pieris.com
Founded: 2001
Full Time Employees: 114
Sector: Healthcare
Industry: Biotechnology
The information provided in this report is taken from www.sec.gov. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.
Day
Week
Month
Date 2024-06-18
P
O 9.99
H 10.00
L 9.10
C 9.23
V 11,093
10EMA 9.23
20EMA 9.23
60EMA 9.23
120EMA 9.23
250EMA 9.23